Changzhou Qianhong Biopharma Co Ltd 002550.SZ

Last Updated: May 15, 12:00 AM·SZSE

Changzhou Qianhong Biopharma Co Ltd

Changzhou Qianhong Biopharma Co Ltd. Stock Analysis 002550.SZ

China Health Care Small Cap
Changzhou Qianhong Biopharma Co., Ltd. manufactures & sells pharmaceutical products. The company is headquartered in Changzhou, Jiangsu and currently employs 1,038 full-time employees. The company went IPO on 2011-02-18. The firm's main products are two series of biochemical drugs: active enzymes and polysaccharides. Among them, the active enzyme varieties mainly include pancreatic kallikreinogenase series, asparaginase series, and compound digestive enzyme capsules II. polysaccharide varieties mainly include heparin sodium and low molecular weight heparin series varieties.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.